White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma

Not recruiting

3 1 1 1
Investigated diseases:
- Mantle cell lymphoma
+5
Study on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma

Not recruiting

3 1 1
Investigated diseases:
- Asthma
Study on Acalabrutinib and Venetoclax for Newly Diagnosed Chronic Lymphocytic Leukemia Patients at High Risk of Infection and Early Treatment Needs

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia
Study of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation

Not recruiting

3 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
+3
Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson’s Disease

Not recruiting

2 1
Investigated diseases:
- Parkinson’s disease
+1
Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated diseases:
- Non-small cell lung cancer
+3
Study on the Effectiveness and Safety of Naporafenib Combinations in Patients with Previously Treated Unresectable or Metastatic Melanoma

Not recruiting

2 1 1
Investigated diseases:
- Metastatic malignant melanoma
- Malignant melanoma
Study of ExPEC9V vaccine for preventing invasive E.

Not recruiting

3 1
Investigated diseases:
- Escherichia urinary tract infection
+1
Study on the Effectiveness and Safety of Vutrisiran and Patisiran for Patients with Hereditary Transthyretin Amyloidosis

Not recruiting

3 1 1 1
Investigated diseases:
- Cardiac amyloidosis
- Hereditary neuropathic amyloidosis
+1
Study on Long-Term Safety and Efficacy of Etranacogene Dezaparvovec for Adults with Severe or Moderately Severe Hemophilia B

Not recruiting

2 1 1 1
Investigated diseases:
- Factor IX deficiency

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies